Business Description
Neurothera Labs Inc
NAICS : 325410
SIC : 3741
ISIN : CA64136J1012
Description
Neurothera Labs Inc is a specialty clinical-stage pharmaceutical company. The company's focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid therapies. With this focus, it has been engaged in developing and testing pharmaceutical compositions comprised of N-acylethanolamines, CBD and/or other cannabinoid receptors agonists. The Company is currently engaged in development programs based on tetrahydrocannabinol and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum disorder and Status Epilepticus.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.82 | |||||
Equity-to-Asset | 0.04 | |||||
Debt-to-Equity | 6.96 | |||||
Debt-to-EBITDA | -6.31 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 18.6 | |||||
3-Year EPS without NRI Growth Rate | 28.2 | |||||
3-Year FCF Growth Rate | 25 | |||||
3-Year Book Growth Rate | -11.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 91.79 | |||||
9-Day RSI | 87.98 | |||||
14-Day RSI | 84.24 | |||||
3-1 Month Momentum % | -34.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 1.3 | |||||
Cash Ratio | 1.23 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -28.09 | |||||
ROA % | -11.06 | |||||
ROIC % | -7.91 | |||||
ROCE % | -16.31 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 172.84 | |||||
EV-to-EBIT | -134 | |||||
EV-to-EBITDA | -134 | |||||
EV-to-FCF | -362.01 | |||||
Earnings Yield (Greenblatt) % | -0.75 | |||||
FCF Yield % | -0.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Neurothera Labs Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.006 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 84.24 | ||
| 14-Day ATR (€) | 0.004732 | ||
| 20-Day SMA (€) | 0.105215 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.0796 - 0.149 | ||
| Shares Outstanding (Mil) | 84.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neurothera Labs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neurothera Labs Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Neurothera Labs Inc Frequently Asked Questions
What is Neurothera Labs Inc(FRA:C0A)'s stock price today?
The current price of FRA:C0A is €0.15. The 52 week high of FRA:C0A is €0.15 and 52 week low is €0.08.
When is next earnings date of Neurothera Labs Inc(FRA:C0A)?
The next earnings date of Neurothera Labs Inc(FRA:C0A) is .
Does Neurothera Labs Inc(FRA:C0A) pay dividends? If so, how much?
Neurothera Labs Inc(FRA:C0A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Neurothera Labs Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers